Skip to main content
Enter the terms you wish to search for.
Select Search Option
This Site
All WCM Sites
Directory
Menu
Weill Cornell Medicine
Care
Discover
Teach
Elemento Lab
Explore this Website
Home
Affiliations
Research
Toggle Research menu options
Big Data Analytics & Machine Learning
Cancer Genomics
Drug Discovery
Epigenomics
Genetics
Mathematical Modeling
Projects
Proteomics
Spatial Computing
Software
Lab Team
Publications
News
Join Us
Weill Cornell Medicine
Care
Discover
Teach
Home
Affiliations
Research
Lab Team
Publications
News
Join Us
Home
Publications
Publications
Found 44 results
Author
Title
Type
Year
Filters:
Author
is
Sboner, Andrea
[Clear All Filters]
2013
Lin P-C
,
Giannopoulou EG
,
Park K
,
Mosquera JMiguel
,
Sboner A
,
Tewari AK
,
Garraway LA
,
Beltran H
,
Rubin MA
,
Elemento O
. 2013.
Epigenomic alterations in localized and advanced prostate cancer.
.
Neoplasia. 15(4):373-83.
Baca SC
,
Prandi D
,
Lawrence MS
,
Mosquera JMiguel
,
Romanel A
,
Drier Y
,
Park K
,
Kitabayashi N
,
MacDonald TY
,
Ghandi M
et al.
. 2013.
Punctuated evolution of prostate cancer genomes.
.
Cell. 153(3):666-77.
2014
Chakravarty D
,
Sboner A
,
Nair SS
,
Giannopoulou E
,
Li R
,
Hennig S
,
Mosquera JMiguel
,
Pauwels J
,
Park K
,
Kossai M
et al.
. 2014.
The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer.
.
Nat Commun. 5:5383.
2015
Robinson D
,
Van Allen EM
,
Wu Y-M
,
Schultz N
,
Lonigro RJ
,
Mosquera J-M
,
Montgomery B
,
Taplin M-E
,
Pritchard CC
,
Attard G
et al.
. 2015.
Integrative Clinical Genomics of Advanced Prostate Cancer.
.
Cell. 162(2):454.
Robinson D
,
Van Allen EM
,
Wu Y-M
,
Schultz N
,
Lonigro RJ
,
Mosquera J-M
,
Montgomery B
,
Taplin M-E
,
Pritchard CC
,
Attard G
et al.
. 2015.
Integrative Clinical Genomics of Advanced Prostate Cancer.
.
Cell. 162(2):454.
Beltran H
,
Eng K
,
Mosquera JMiguel
,
Sigaras A
,
Romanel A
,
Rennert H
,
Kossai M
,
Pauli C
,
Faltas B
,
Fontugne J
et al.
. 2015.
Whole-Exome Sequencing of Metastatic Cancer and Biomarkers of Treatment Response.
.
JAMA Oncol. 1(4):466-74.
2016
Faltas BM
,
Prandi D
,
Tagawa ST
,
Molina AM
,
Nanus DM
,
Sternberg C
,
Rosenberg J
,
Mosquera JMiguel
,
Robinson B
,
Elemento O
et al.
. 2016.
Clonal evolution of chemotherapy-resistant urothelial carcinoma.
.
Nat Genet. 48(12):1490-1499.
Rennert H
,
Eng K
,
Zhang T
,
Tan A
,
Xiang J
,
Romanel A
,
Kim R
,
Tam W
,
Liu Y-C
,
Bhinder B
et al.
. 2016.
Development and validation of a whole-exome sequencing test for simultaneous detection of point mutations, indels and copy-number alterations for precision cancer care.
.
NPJ Genom Med. 1
Beltran H
,
Prandi D
,
Mosquera JMiguel
,
Benelli M
,
Puca L
,
Cyrta J
,
Marotz C
,
Giannopoulou E
,
Chakravarthi BVSK
,
Varambally S
et al.
. 2016.
Divergent clonal evolution of castration-resistant neuroendocrine prostate cancer.
.
Nat Med. 22(3):298-305.
Dardenne E
,
Beltran H
,
Benelli M
,
Gayvert K
,
Berger A
,
Puca L
,
Cyrta J
,
Sboner A
,
Noorzad Z
,
MacDonald T
et al.
. 2016.
N-Myc Induces an EZH2-Mediated Transcriptional Program Driving Neuroendocrine Prostate Cancer.
.
Cancer Cell. 30(4):563-577.
Sboner A
,
Elemento O
. 2016.
A primer on precision medicine informatics.
.
Brief Bioinform. 17(1):145-53.
2017
Huang L
,
Fernandes H
,
Zia H
,
Tavassoli P
,
Rennert H
,
Pisapia D
,
Imielinski M
,
Sboner A
,
Rubin MA
,
Kluk M
et al.
. 2017.
The cancer precision medicine knowledge base for structured clinical-grade mutations and interpretations.
.
J Am Med Inform Assoc. 24(3):513-519.
Romanel A
,
Garritano S
,
Stringa B
,
Blattner M
,
Dalfovo D
,
Chakravarty D
,
Soong D
,
Cotter KA
,
Petris G
,
Dhingra P
et al.
. 2017.
Inherited determinants of early recurrent somatic mutations in prostate cancer.
.
Nat Commun. 8(1):48.
Pisapia DJ
,
Salvatore S
,
Pauli C
,
Hissong E
,
Eng K
,
Prandi D
,
Sailer V-W
,
Robinson BD
,
Park K
,
Cyrta J
et al.
. 2017.
Next-Generation Rapid Autopsies Enable Tumor Evolution Tracking and Generation of Preclinical Models.
.
JCO Precis Oncol. 2017
Pauli C
,
Hopkins BD
,
Prandi D
,
Shaw R
,
Fedrizzi T
,
Sboner A
,
Sailer V
,
Augello M
,
Puca L
,
Rosati R
et al.
. 2017.
Personalized and Cancer Models to Guide Precision Medicine.
.
Cancer Discov. 7(5):462-477.
2018
Sailer V
,
Schiffman MH
,
Kossai M
,
Cyrta J
,
Beg S
,
Sullivan B
,
Pua BB
,
Lee KSteve
,
Talenfeld AD
,
Nanus DM
et al.
. 2018.
Bone biopsy protocol for advanced prostate cancer in the era of precision medicine.
.
Cancer. 124(5):1008-1015.
Puca L
,
Bareja R
,
Prandi D
,
Shaw R
,
Benelli M
,
Karthaus WR
,
Hess J
,
Sigouros M
,
Donoghue A
,
Kossai M
et al.
. 2018.
Patient derived organoids to model rare prostate cancer phenotypes.
.
Nat Commun. 9(1):2404.
2019
Glynn S
,
Lipkin S
,
Zhang T
,
Sboner A
,
Elemento O
,
van Besien K
,
Beltran H
. 2019.
The application of precision medicine in diagnosing familial Mediterranean fever.
.
Leuk Lymphoma. 60(8):2091-2093.
Fernandez EM
,
Eng K
,
Beg S
,
Beltran H
,
Faltas BM
,
Mosquera JMiguel
,
Nanus DM
,
Pisapia DJ
,
Rao RA
,
Robinson BD
et al.
. 2019.
Cancer-Specific Thresholds Adjust for Whole Exome Sequencing-based Tumor Mutational Burden Distribution.
.
JCO Precis Oncol. 3
Augello MA
,
Liu D
,
Deonarine LD
,
Robinson BD
,
Huang D
,
Stelloo S
,
Blattner M
,
Doane AS
,
Wong EWP
,
Chen Y
et al.
. 2019.
CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate Tumorigenesis.
.
Cancer Cell. 35(5):817-819.
Augello MA
,
Liu D
,
Deonarine LD
,
Robinson BD
,
Huang D
,
Stelloo S
,
Blattner M
,
Doane AS
,
Wong EWP
,
Chen Y
et al.
. 2019.
CHD1 Loss Alters AR Binding at Lineage-Specific Enhancers and Modulates Distinct Transcriptional Programs to Drive Prostate Tumorigenesis.
.
Cancer Cell. 35(4):603-617.e8.
Conteduca V
,
Oromendia C
,
Eng KW
,
Bareja R
,
Sigouros M
,
Molina A
,
Faltas BM
,
Sboner A
,
Mosquera JMiguel
,
Elemento O
et al.
. 2019.
Clinical features of neuroendocrine prostate cancer.
.
Eur J Cancer. 121:7-18.
Puca L
,
Gavyert K
,
Sailer V
,
Conteduca V
,
Dardenne E
,
Sigouros M
,
Isse K
,
Kearney M
,
Vosoughi A
,
Fernandez L
et al.
. 2019.
Delta-like protein 3 expression and therapeutic targeting in neuroendocrine prostate cancer.
.
Sci Transl Med. 11(484)
Musselman K
,
Glynn S
,
Mosquera JMiguel
,
Elemento O
,
Sboner A
,
Beltran H
,
Holcomb K
. 2019.
Identification of a therapeutic target using molecular sequencing for treatment of recurrent uterine serous adenocarcinoma.
.
Gynecol Oncol Rep. 28:54-57.
Sailer V
,
Eng KWa
,
Zhang T
,
Bareja R
,
Pisapia DJ
,
Sigaras A
,
Bhinder B
,
Romanel A
,
Wilkes D
,
Sticca E
et al.
. 2019.
Integrative Molecular Analysis of Patients With Advanced and Metastatic Cancer.
.
JCO Precis Oncol. 3
1
(current)
2
next ›
last »